Key Insights

Highlights

Treatment Research

1 treatments under study, led by Clinical Decision Support Tool

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07890415Phase 3Recruiting

Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis

Showing all 1 trials

Research Network

Common Treatments

  • Clinical Decision Support Tool1

Active Sponsors

  • Canfield Scientific Inc.1
  • Memorial Sloan Kettering Cancer Center1
  • National Institutes of Health (NIH)1

Top Investigators

Related Conditions

  • Malignant Melanoma Of Skin1
  • Neoplasm Of Unspecified Behavior Of Bone Soft Tissue And Skin1
  • Neoplasm Of Uncertain Behavior Of Skin1
  • Congenital Nonneoplastic Naevus1
  • Hemangioma1

Activity Timeline